According to RIA Novosti with reference to these departments, the ministry approved the seventh version of the guidelines for the treatment of the disease.
In particular, the document presents new treatment regimens for COVID-19 using new drugs.
Earlier, the Russian Ministry of Health approved the drug against the coronavirus Avifavir.
The register of medicines specifies that the trade name of the drug is Avifavir, and the international non-proprietary (or grouping, or chemical) name is favipiravir.
On May 13, the RDIF and the ChemRar group of companies announced the first interim positive results of a clinical study of favipiravir in patients hospitalized with coronavirus infection.